Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European heart rhythm association survey

Europace

Volumn 15, Issue 4, 2013, Pages 478-481

  Dagres, Nikolaos ^a   Lewalter, Thorsten ^b   Lip, Gregory Y H ^c   Pison, Laurent ^d   Proclemer, Alessandro ^e   Blomström Lundqvist, Carina ^f  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Isarklinikum Munich   (Germany)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY HOSPITAL OF UDINE   (Italy)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; EHRA survey; Proarrhythmia; Rhythm control

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DRONEDARONE; FLECAINIDE; PROPAFENONE; SOTALOL;

ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CLINICAL PRACTICE; DRUG CHOICE; DRUG EFFICACY; EUROPE; HEALTH CARE SURVEY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART PROARRHYTHMIA; HEART RHYTHM; HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; QRS COMPLEX; QT INTERVAL;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COMORBIDITY; ELECTROCARDIOGRAPHY; EUROPE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RECURRENCE; TREATMENT OUTCOME;

EID: 84875982416     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut063     Document Type: Article

References (9)

1. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
2. Chinitz JS, Halperin JL, Reddy VY, Fuster V. Rate or rhythm control for atrial fibrillation: update and controversies. Am J Med 2012;125:1049-56.
3. Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, Essebag V, Eisenberg MJ, Wynant W et al. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med 2012;172:997-1004.
4. De Vos CB, Breithardt G, Camm AJ, Dorian P, Kowey PR, Le Heuzey JY et al. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythmcontrol therapy. Am Heart J 2012;163:887-93.
5. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010;12: 1360-420.
6. Tsadok MA, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH et al. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 2012;126:2680-7.
7. Chen S, Yin Y, Krucoff MW. Should rhythm control be preferred in younger atrial fibrillation patients?. J Interv Card Electrophysiol 2012;35:71-80.
8. Ku?hlkamp V, Schirdewan A, Stangl K, Homberg M, Ploch M, Beck OA. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 2000;36:139-46.
9. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Europace 2012;14:1385-413.